Molina Healthcare (MOH)
(Delayed Data from NYSE)
$325.43 USD
-4.87 (-1.47%)
Updated Oct 10, 2024 04:00 PM ET
After-Market: $325.51 +0.08 (0.02%) 4:18 PM ET
3-Hold of 5 3
A Value F Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$325.43 USD
-4.87 (-1.47%)
Updated Oct 10, 2024 04:00 PM ET
After-Market: $325.51 +0.08 (0.02%) 4:18 PM ET
3-Hold of 5 3
A Value F Growth D Momentum D VGM
Zacks News
Pick These 4 Stocks With Excellent Interest Coverage Ratio
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. MOD, EG, HLT and MOH are sound enough to meet financial obligations.
Molina Healthcare, Inc (MOH) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Molina (MOH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
HCA Healthcare (HCA) Unveils Ambitious 5-Year Growth Targets
by Zacks Equity Research
Over the five-year horizon, HCA Healthcare (HCA) anticipates substantial 8-12% annual growth in earnings per share.
Is Centene (CNC) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Brookdale Senior (BKD) Shares Rise 1.9% Despite Q3 Earnings Miss
by Zacks Equity Research
Brookdale Senior (BKD) expects adjusted EBITDA to be within the $77-$82 million range in the fourth quarter.
Select Medical (SEM) Stock Down 6.6% Despite Q3 Earnings Beat
by Zacks Equity Research
Select Medical (SEM) continues to expect adjusted EBITDA to be between $795 million and $825 million in 2023.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cigna (CI) Q3 Earnings Beat on Membership Growth, '23 EPS View Up
by Zacks Equity Research
Cigna's (CI) Q3 results benefit on well-performing U.S. Commercial and Medicare Advantage businesses. Management currently expects 2023 adjusted EPS to be a minimum of $24.75.
Humana (HUM) Q3 Earnings Beat on Strong Individual MA Unit
by Zacks Equity Research
Humana (HUM) continues to project 2023 adjusted EPS at a minimum of $28.25, which suggests growth from the 2022 figure of $25.88.
Molina (MOH) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Molina (MOH) possesses solid growth attributes, which could help it handily outperform the market.
Encompass Health's (EHC) Q3 Earnings Beat on Discharge Growth
by Zacks Equity Research
Encompass Health's (EHC) Q3 results benefit from an increase in patient volumes and net patient revenue per discharge. Management currently projects adjusted EPS to be within $3.41-$3.52 for 2023.
Molina Healthcare (MOH) Q3 Earnings Beat on Membership Growth
by Zacks Equity Research
Molina Healthcare's (MOH) third-quarter results gain from changes in the member mix and a growing premium base. Management reiterates its 2023 adjusted EPS guidance to be a minimum of $20.75.
Universal Health (UHS) Q3 Earnings Beat on Adjusted Patient Days
by Zacks Equity Research
Universal Health (UHS) has a leftover repurchase capacity of around $580 million as of Sep 30, 2023.
Here's What Key Metrics Tell Us About Molina (MOH) Q3 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for Molina (MOH) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Molina (MOH) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Molina (MOH) delivered earnings and revenue surprises of 3.70% and 2.94%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Centene (CNC) Q3 Earnings Beat on Commercial Growth, View Raised
by Zacks Equity Research
Centene (CNC) anticipates adjusted EPS to register a minimum of $6.60 this year.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Will the Medicare Unit Aid Molina Healthcare's (MOH) Q3 Earnings?
by Zacks Equity Research
Molina Healthcare's (MOH) Q3 results are expected to benefit on growing premiums and an expanding customer base within its Medicaid and Medicare businesses, partly offset by increased medical costs.
Take the Zacks Approach to Beat the Market: Novo Nordisk, Amgen, Fabrinet in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Here's Why Molina (MOH) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
UnitedHealth Group's (UNH) Arm OptumRx Expands in Arizona
by Zacks Equity Research
UnitedHealth Group (UNH) is set to enhance the offerings of OptumRx with the recent expansion of pharmacy care services in Arizona.
Should Value Investors Buy Molina Healthcare (MOH) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks.com featured highlights Stride, Deckers Outdoor, Molina Healthcare and McKesson
by Zacks Equity Research
Stride, Deckers Outdoor, Molina Healthcare and McKesson have been highlighted in this Screen of The Week article.
Here's Why You Should Hold Centene (CNC) in Your Portfolio
by Zacks Equity Research
Robust revenue growth outlook, contract wins, accretive acquisitions and streamlining of businesses poise Centene (CNC) well for growth.
4 Stocks That Flaunt an Impressive Interest Coverage Ratio
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. LRN, DECK, MOH and MCK and are sound enough to meet financial obligations.